The FDA announced on April 1, 2026, that International Medication Systems Ltd. is recalling Epinephrine Injection, USP due to a lack of assurance of sterility. The voluntary Class II recall affects 81,520 units distributed nationwide.
How to tell if you have it
- Brand: International Medication Systems
- Product: EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only
- NDC: 76329-3318-1
- Lot Number: EA038A5
- Expiration Date: 08/2026
The hazard
The recall addresses a lack of assurance of sterility in the affected epinephrine injection units. The FDA record does not report specific incidents or injuries associated with this recall.
Context
GovInfoNow's records show other recent recalls of similar products include Reliance Pemetrexed Injection Recall: Sterility Risk in IV Doses (2026-06-24) and American Regent Epinephrine Injection Recall: Particulate Matter Risk (2026-08-11). Additional recent recalls of similar products include Reliance Pemetrexed Injection Recall: Lack of Sterility Risk (2026-06-24).